Beta-catenin inhibits melanocyte migration but induces melanoma metastasis

Oncogene

Volumn 32, Issue 17, 2013, Pages 2230-2238

  Gallagher, S J ^a,b   Rambow, F ^a,b   Kumasaka, M ^a,b   Champeval, D ^a,b   Bellacosa, A ^c   Delmas, V ^a,b   Larue, L ^a,b  

^a INSTITUT CURIE   (France)

^b Centre National de la Recherche Scientifique   (France)

^c FOX CHASE CANCER CENTER   (United States)

Author keywords

CSK; melanoblast; melanoma; MITF; mouse; Wnt

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL LINEAGE; CELL MIGRATION; CELL NUCLEUS; CELL TYPE; EMBRYO; LUNG METASTASIS; MELANOCYTE; MELANOMA; METASTASIS; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TUMOR INVASION;

ANIMALS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; GTP PHOSPHOHYDROLASES; HUMANS; LUNG NEOPLASMS; MELANOCYTES; MELANOMA; MEMBRANE PROTEINS; MICE; MICE, NUDE; MICE, TRANSGENIC; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; NEOPLASM TRANSPLANTATION; SRC-FAMILY KINASES; WNT SIGNALING PATHWAY;

MURINAE;

EID: 84876903398     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2012.229     Document Type: Article

References (32)

1. Lugli A, Zlobec I, Minoo P, Baker K, Tornillo L, Terracciano L et al. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis. Histopathology 2007; 50: 453-464. (Pubitemid 46328181)
2. Baldus SE, Monig SP, Huxel S, Landsberg S, Hanisch FG, Engelmann K et al. MUC1 and nuclear beta-catenin are coexpressed at the invasion front of colorectal carcinomas and are both correlated with tumor prognosis. Clin Cancer Res 2004; 10: 2790-2796. (Pubitemid 38509157)
3. Bachmann IM, Straume O, Puntervoll HE, Kalvenes MB, Akslen LA. Importance of P-cadherin, beta-catenin, and Wnt5a/frizzled for progression of melanocytic tumors and prognosis in cutaneous melanoma. Clin Cancer Res 2005; 11(24 Pt 1): 8606-8614. (Pubitemid 43005907)
4. Chien AJ, Moore EC, Lonsdorf AS, Kulikauskas RM, Rothberg BG, Berger AJ et al. Activated Wnt/beta-catenin signaling in melanoma is associated with decreased proliferation in patient tumors and a murine melanoma model. Proc Natl Acad Sci USA 2009; 106: 1193-1198.
5. Larue L, Beermann F. Cutaneous melanoma in genetically modified animals Pigment. Cell Res 2007; 20: 485-497. (Pubitemid 47568832)
6. Luciani F, Champeval D, Herbette A, Denat L, Aylaj B, Martinozzi S et al. Biological and mathematical modeling of melanocyte development. Development 2011; 138: 3943-3954.
7. Delmas V, Beermann F, Martinozzi S, Carreira S, Ackermann J, Kumasaka M et al. Beta-catenin induces immortalization of melanocytes by suppressing p16INK4a expression and cooperates with N-Ras in melanoma development. Genes Dev 2007; 21: 2923-2935. (Pubitemid 350133440)
8. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of beta-catenin affects mouse development at gastrulation. Development 1995; 121: 3529-3537. (Pubitemid 3000446)
9. Arozarena I, Bischof H, Gilby D, Belloni B, Dummer R, Wellbrock C. In melanoma, beta-catenin is a suppressor of invasion. Oncogene 2011; 30: 4531-4543.
10. Sinnberg T, Menzel M, Ewerth D, Sauer B, Schwarz M, Schaller M et al. Beta-catenin signaling increases during melanoma progression and promotes tumor cell survival and chemoresistance. PLoS One 2011; 6: e23429.
11. Eichhoff OM, Weeraratna A, Zipser MC, Denat L, Widmer DS, Xu M et al. Differential LEF1 and TCF4 expression is involved in melanoma cell phenotype switching. Pigment Cell Melanoma Res 2011; 24: 631-642.
12. Carreira S, Goodall J, Denat L, Rodriguez M, Nuciforo P, Hoek KS et al. Mitf regulation of Dia1 controls melanoma proliferation and invasiveness. Genes Dev 2006; 20: 3426-3439. (Pubitemid 44969160)
13. Larue L, Delmas V. The WNT/Beta-catenin pathway in melanoma. Front Biosci 2006; 11: 733-742. (Pubitemid 43258176)
14. de Melker AA, Desban N, Duband JL. Cellular localization and signaling activity of beta-catenin in migrating neural crest cells. Dev Dyn 2004; 230: 708-726. (Pubitemid 38993870)
15. Murakami T, Toda S, Fujimoto M, Ohtsuki M, Byers HR, Etoh T et al. Constitutive activation of Wnt/beta-catenin signaling pathway in migration-Active melanoma cells: role of LEF-1 in melanoma with increased metastatic potential. Biochem Biophys Res Commun 2001; 288: 8-15. (Pubitemid 32999718)
16. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM. Molecular interactions in cancer cell metastasis. Acta Histochem 2010; 112: 3-25.
17. Damsky WE, Curley DP, Santhanakrishnan M, Rosenbaum LE, Platt JT, Gould Rothberg BE et al. Beta-catenin signaling controls metastasis in Braf-Activated Pten-deficient melanomas. Cancer Cell 2011; 20: 741-754.
18. Mackenzie MA, Jordan SA, Budd PS, Jackson IJ. Activation of the receptor tyrosine kinase Kit is required for the proliferation of melanoblasts in the mouse embryo. Dev Biol 1997; 192: 99-107. (Pubitemid 28015649)
19. Delmas V, Martinozzi S, Bourgeois Y, Holzenberger M, Larue L. Cre-mediated recombination in the skin melanocyte lineage. Genesis 2003; 36: 73-80. (Pubitemid 36818665)
20. Bottomly D, Kyler SL, McWeeney SK, Yochum GS. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res 2010; 38: 5735-5745.
21. Hoek KS, Schlegel NC, Brafford P, Sucker A, Ugurel S, Kumar R et al. Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature. Pigment Cell Res 2006; 19: 290-302. (Pubitemid 44015592)
22. Guarino M. Src signaling in cancer invasion. J Cell Physiol 2010; 223: 14-26.
23. Ackermann J, Frutschi M, Kaloulis K, McKee T, Trumpp A, Beermann F. Metastasizing melanoma formation caused by expression of activated N-RasQ61K on an INK4a-deficient background. Cancer Res 2005; 65: 4005-4011. (Pubitemid 40775636)
24. Kielhorn E, Provost E, Olsen D, D'Aquila TG, Smith BL, Camp RL et al. Tissue microarray-based analysis shows phospho-beta-catenin expression in malignant melanoma is associated with poor outcome. Int J Cancer 2003; 103: 652-656. (Pubitemid 36091470)
25. Kageshita T, Hamby CV, Ishihara T, Matsumoto K, Saida T, Ono T. Loss of beta-catenin expression associated with disease progression in malignant melanoma. Br J Dermatol 2001; 145: 210-216. (Pubitemid 32955344)
26. Omholt K, Platz A, Ringborg U, Hansson J. Cytoplasmic and nuclear accumulation of beta-catenin is rarely caused by CTNNB1 exon 3 mutations in cutaneous malignant melanoma. Int J Cancer 2001; 92: 839-842. (Pubitemid 32467373)
27. Widlund HR, Horstmann MA, Price ER, Cui J, Lessnick SL, Wu M et al. Beta-catenininduced melanoma growth requires the downstream target Microphthalmiaassociated transcription factor. J Cell Biol 2002; 158: 1079-1087.
28. Schepsky A, Bruser K, Gunnarsson GJ, Goodall J, Hallsson JH, Goding CR et al. The microphthalmia-Associated transcription factor Mitf interacts with beta-catenin to determine target gene expression. Mol Cell Biol 2006; 26: 8914-8927. (Pubitemid 44851949)
29. Bennett DC, Cooper PJ, Dexter TJ, Devlin LM, Heasman J, Nester B. Cloned mouse melanocyte lines carrying the germline mutations albino and brown: complementation in culture. Development 1989; 105: 379-385. (Pubitemid 19053284)
30. Gallagher SJ, Luciani F, Berlin I, Rambow F, Gros G, Champeval D et al. General strategy to analyse melanoma in mice. Pigment Cell Melanoma Res 2011; 24: 987-988.
31. Korinek V, Barker N, Morin PJ, van Wichen D, de Weger R, Kinzler KW et al. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/-colon carcinoma. Science 1997; 275: 1784-1787. (Pubitemid 27136714)
32. Larue L, Antos C, Butz S, Huber O, Delmas V, Dominis M et al. A role for cadherins in tissue formation. Development 1996; 122: 3185-3194. (Pubitemid 26371983)